{"disease":{"id":"crow-s-feet","name":"crow s feet"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01189760","title":"Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":917,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT02248844","title":"Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea","phase":"","overall_status":"COMPLETED","enrollment_count":667,"lead_sponsor_name":"Allergan","has_results":false},{"nct_id":"NCT01189747","title":"Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":446,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT01797081","title":"BOTOX® in the Treatment of Crow's Feet Lines in Japan","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT04985916","title":"ET-01 in Subjects With Lateral Canthal Lines, LCL-210","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"Eirion Therapeutics Inc.","has_results":false},{"nct_id":"NCT06703294","title":"A Prospective, Multicenter, Blind, Randomized Controlled, Optimal Clinical Trial to Evaluate the Safety and Efficacy of Medical Collagen Fillers for Facial Dermal Tissue Filling to Correct Frontal Wrinkles (crow's Feet)","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":260,"lead_sponsor_name":"Fiman (Changchun) Pharmaceutical Biotechnology Company Limited","has_results":false},{"nct_id":"NCT03317574","title":"MEDITOXIN® in Treatment of Crow's Feet Line","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Medy-Tox","has_results":false},{"nct_id":"NCT03408236","title":"Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Hugel","has_results":false},{"nct_id":"NCT06376838","title":"To Prove the Non-inferiority of DLMR01 by Evaluating the Injecting Efficacy and Safety DLMR01 and Control for Patients in Crow's Feet","phase":"NA","overall_status":"COMPLETED","enrollment_count":218,"lead_sponsor_name":"DEXLEVO","has_results":false},{"nct_id":"NCT06428253","title":"Efficacy and Safety of HMM1-022 in Temporary Correction of Crow's Feet","phase":"NA","overall_status":"COMPLETED","enrollment_count":171,"lead_sponsor_name":"Humedix Co., Ltd.","has_results":false},{"nct_id":"NCT02176356","title":"Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT06021418","title":"Efficacy and Safety of DKB-119 in Patients in Crow's Feet","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Dongkook Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04818203","title":"A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"S.Biomedics Co., Ltd.","has_results":false},{"nct_id":"NCT03655691","title":"ET-01 in Subjects With Lateral Canthal Lines, LCL-207","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"Eirion Therapeutics Inc.","has_results":true},{"nct_id":"NCT03839693","title":"ET-01 in Subjects With Lateral Canthal Lines, LCL-208","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Eirion Therapeutics Inc.","has_results":true},{"nct_id":"NCT06402058","title":"A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Samyang Biopharmaceuticals Corporation","has_results":false},{"nct_id":"NCT03326856","title":"ET-01 in Subjects With Lateral Canthal Lines","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Eirion Therapeutics Inc.","has_results":true},{"nct_id":"NCT03912805","title":"ET-01 in Subjects With Lateral Canthal Lines, LCL-209","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Eirion Therapeutics Inc.","has_results":true},{"nct_id":"NCT07028203","title":"Non-invasive Rejuvenation of the Periorbital Area and Lower Eyelid","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30,"lead_sponsor_name":"BTL Industries Ltd.","has_results":false},{"nct_id":"NCT07374965","title":"A Prospective, Non-Interventional, Single-Centre Study Assessing the Efficacy of a Holistic Upper Face Treatment With Botulinum Neurotoxin A","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Yuvell","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}